HEALTH POLICY / ETHICSA Rooming-in Program to Mitigate the Need to Treat for Opiate Withdrawal in the Newborn
REFERENCES (26)
- et al.
Opioid dependence during pregnancy
Obstet Gynecol Clin N Am
(1998) - et al.
Observation and treatment of neonatal narcotic withdrawal
Am J Obstet Gynecol
(1977) - et al.
Relationship between maternal methadone dosage and neonatal withdrawal
Obstet Gynecol
(2002) - et al.
Maternal methadone dose and neonatal withdrawal
Am J Obstet Gynecol
(2003) - et al.
High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes
Am J Obstet Gynecol
(2005) - et al.
Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates
Am J Obstet Gynecol
(2008) - et al.
Methadone and perinatal outcomes: a retrospective cohort study
Am J Obstet Gynecol
(2011) - et al.
Is neonatal abstinence syndrome related to the amount of opiate used?
J Obstet Gynecol Neonatal Nurs
(2010) - et al.
High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome
Am J Obstet Gynecol
(2009) - et al.
An evaluation of rooming-in among substanceexposed newborns in British Columbia
J Obstet Gynaecol Can
(2010)
Nicotine withdrawal symptoms in newborns
Arch Bronconeumol
Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome
Am J Obstet Gynecol
Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis
Lancet
Cited by (43)
The harms of punishing substance use during pregnancy
2021, International Journal of Drug PolicyClinical care of neonates undergoing opioid withdrawal in the immediate postpartum period
2021, Neurotoxicology and TeratologyCitation Excerpt :The practice known as “rooming-in” encourages caregivers to stay in the hospital with the infant overnight to integrate them into patient care. As with breast milk, infants that experience rooming-in exhibit decreased need for and decreased duration of any necessary pharmacological treatment, as well as a reduced hospital LOS (Hodgson and Abrahams, 2012; MacMillan et al., 2018). Non-pharmacological interventions should also extend to the mother to assist in establishing her role as a stable and reliable primary caregiver for the infant (Fig. 1) (Grossman et al., 2018a; Wachman et al., 2018b).
Introduction
2019, Seminars in PerinatologyBreastmilk feeding for mothers and infants with opioid exposure: What is best?
2019, Seminars in Fetal and Neonatal MedicineCitation Excerpt :These two reports support the notion that the small amount of methadone received in their mother's breastmilk may help opioid-exposed infants experience less severe NOWS. On the other hand, Hogsdon et al. examined outcomes for infants whose mothers were predominantly prescribed methadone, and in addition to demonstrating a reduced pharmacologic treatment rate for those ever breastfed, they anecdotally reported that infants initially breastfed and then switched to formula did not require pharmacologic treatment, suggesting the role played by methadone in breastmilk in lessening NOWS symptoms may instead be minimal [49]. Interestingly, there are no reports of infants experiencing acute withdrawal symptoms with cessation of breastfeeding when infants are older.
Neonatal abstinence syndrome
2019, Seminars in PerinatologyCitation Excerpt :Rooming-in allows for increased skin-skin time and may improve success in establishing breastfeeding. The reports also identify the importance of delivering an empowering message to the parents so they understand the magnitude of their involvement in the care of their infants, with certain centers developing prenatal counseling visits to set expectations for parental roles in the postnatal care of their infant.116 To date, these studies have shown some of the greatest reductions in length of stay with reported length of stay as low as 6 days for infants with NAS.
Competing Interests: None declared.